Novo Nordisk A/S ADR buy Argus
Start price
02.10.23
/
50%
€85.60
Target price
02.10.24
€104.76
Performance (%)
46.12%
Price
19:14
€124.00
Summary
This prediction is currently active. With a performance of 46.12% the BUY prediction by Argus is a big success. Dividends of €1.08 are taken into consideration when calculating the performance. This prediction currently runs until 02.10.24. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 0.000% | 0.000% |
| iShares Core DAX® | 1.743% | 1.903% |
| iShares Nasdaq 100 | -2.088% | -0.640% |
| iShares Nikkei 225® | 1.306% | 4.161% |
| iShares S&P 500 | -0.093% | 0.169% |
Comments by Argus for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Argus. They set a "buy" rating and a $110.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Argus for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€132.00
10.06.24
10.06.24
€148.83
10.06.25
10.06.25
-6.09%
19:14
19:14
